TB-CHAMP试验:年幼儿童接触耐多药结核感染的風險
TB-CHAMP多中心随机对照试验纳入785名年龄小于5岁的耐多药肺结核成人家庭接触儿童,基线IGRA阳性率为20.4%。指示病例咳嗽持续时间、药物滥用、儿童年龄、儿童与指示病例关系及研究中心与感染风险显著相关。感染率低于既往研究,可能因研究地区耐多药结核诊治改善及/或检测局限性所致。
要点
- 785名小于5岁家庭接触儿童中160名(20.4%)基线IGRA阳性。
- 指示病例咳嗽持续时间、药物滥用、儿童年龄、儿童与指示病例关系及研究中心与感染风险显著相关。
- 为儿童接触者考虑结核预防治疗时,应特别关注由父母/主要照护者暴露、有慢性咳嗽和/或药物滥用史的成人指示病例所暴露的幼儿。
核心结论
- 儿童家庭接触者耐多药结核感染率为20.4%,低于既往研究观察到的水平。
- 指示病例咳嗽持续时间、药物滥用、儿童年龄、儿童与指示病例关系及研究中心与IGRA阳性风险显著相关。
研究设计与样本
- TB-CHAMP是一项耐多药结核预防试验,招募年龄小于5岁的儿童,不论其结核分枝杆菌感染状态。
- 所有入组儿童均在基线接受干扰素-γ释放试验(IGRA)。
- 共纳入785名儿童;采用有向无环图阐明因果关系,并使用改良Poisson回归模型评估危险因素与IGRA阳性之间的关系。
主要发现
- 785名纳入儿童中,160名(20.4%)IGRA阳性。
- 指示病例的咳嗽持续时间和药物滥用、儿童年龄、儿童与指示病例的关系及研究中心与感染风险显著相关。
关键数值与推荐
- 儿童家庭接触者(年龄小于5岁)耐多药结核感染率为20.4%(160/785)。
临床怎么用
- 为儿童接触者考虑结核预防治疗时,医疗提供者应特别关注暴露于以下成人指示病例的幼儿:该指示病例为其父母/主要照护者、有慢性咳嗽和/或药物滥用史。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Young children have a high risk of developing tuberculosis (TB) disease following infection with Mycobacterium tuberculosis in the absence of preventive treatment. Infection prevalence and risk factors for infection impact delivery of prevention strategies. We aimed to determine the prevalence of infection in child household contacts aged <5 years exposed to adults with confirmed pulmonary multidrug-resistant (MDR)-TB and to determine risk factors for infection. METHODS: TB-CHAMP was a trial of MDR-TB prevention that recruited children younger than age 5 years, regardless of M. tuberculosis infection status. All children enrolled had an interferon-gamma release assay (IGRA) at baseline. We described M. tuberculosis infection prevalence, developed directed acyclic graphs to clarify causal relationships, and used modified Poisson regression models to assess the relationship between risk factors and IGRA positivity. RESULTS: Of 785 included children, 160 (20.4%) had a positive IGRA. Duration of cough and drug misuse in the index patient, age of the child, relationship between the child and the index patient, and study site were significantly associated with risk of infection. CONCLUSIONS: The prevalence of infection was lower than observed in previous studies. This may be related to improved diagnosis and treatment of MDR-TB in the study setting and/or test limitations and has implications for TB preventive treatment. When considering TB preventive treatment for child contacts, healthcare providers should be especially concerned about any young child exposed to an adult index patient who is his/her parent/primary caregiver, has a chronic cough, and/or a history of drug misuse.
引用
- Purchase SE, Brigden J, Seddon JA, et al. Risk of Tuberculosis Infection in Young Children Exposed to Multidrug-resistant Tuberculosis in the TB-CHAMP Multi-site Randomized Controlled Trial. Clin Infect Dis. 2025. PMID: 40440402. doi:10.1093/cid/ciaf284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。